Skip to content
June 08, 2023

Equity.Guru

Investment information for the new generation

RVV.C

Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S….
The COVID-19 pandemic and variant friends are almost securely in our rear-view for another year and soon the beaches will be full of people and the papers will be…
Revive Therapeutics (RVV.C) provided an update on their psilocybin development programs today. “Revive is building a specialty psilocybin-based product pipeline to treat mental illness, substance abuse and neurological disorders….
Detroit, Michigan city officials announced on Monday that they had decriminalized psychedelics, becoming the latest municipality to pull back on law enforcement when it comes to plant-based mind-manifesting substances….
Naturally occurring psychedelic compounds such as DMT in ayahuasca, psilocybin in magic mushrooms, salvinorum A found in the salvia divinorum mint species, mescaline from peyote cacti and the scolpolamine…
Last week, I was asked at least a dozen times by market professionals, “What sector do you like right now?” Normally that’s an easy question to ask as there’s…
Latest News Revive Therapeutics Ltd. (RVV.C) has provided an update for the Company’s U.S. Food and Drug Administration (FDA) Phase 3 clinical trial to evaluate the safety and efficacy…
Revive Therapeutics (“RVV.C”) is a life sciences company that focuses on the research and development of therapeutics for rare disorders and infectious diseases. and it is prioritizing drug development…
Revive Therapeutics (RVV.C) is an interesting play. You like cannabis and its health benefits? Revive Therapeutics is one to add on your list. Maybe you are more bullish Psychedelics?…
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly,…